IRIS
FOLI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 344
AS - Asia 266
EU - Europa 233
AF - Africa 2
OC - Oceania 1
Totale 846
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 341
CN - Cina 228
IE - Irlanda 128
FI - Finlandia 36
DE - Germania 33
SG - Singapore 20
IT - Italia 19
JP - Giappone 11
SE - Svezia 6
GB - Regno Unito 4
IN - India 4
FR - Francia 3
CA - Canada 2
ES - Italia 2
IR - Iran 2
AT - Austria 1
AU - Australia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
MX - Messico 1
PH - Filippine 1
SL - Sierra Leone 1
Totale 846
Salva come PNG Salva come JPEG
Città #
Dublin 128
Chandler 106
Nanjing 57
Beijing 45
Helsinki 22
Jacksonville 22
Nanchang 22
Ashburn 19
Shenyang 18
Singapore 18
Princeton 17
Boardman 16
Hebei 16
Lawrence 16
Tianjin 15
Changsha 13
Medford 13
Pavia 13
Wilmington 12
Shanghai 11
Tokyo 11
Jiaxing 10
Hangzhou 6
Piscataway 6
Munich 4
Norwalk 4
Pune 4
Tamm 4
Falkenstein 3
Woodbridge 3
Zhengzhou 3
Chicago 2
Fuzhou 2
New York 2
Ningbo 2
Taizhou 2
Vinovo 2
Ann Arbor 1
Brno 1
Cairo 1
Cervera del Rio Alhama 1
Dallas 1
Dearborn 1
Fairfield 1
Freetown 1
Haikou 1
Houston 1
Jinan 1
London 1
Manila 1
Markham 1
Nagold 1
Orange 1
Redwood City 1
Saint-Alexis-de-Matapedia 1
San Francisco 1
Seattle 1
Shiraz 1
Sydney 1
Vienna 1
Totale 692
Salva come PNG Salva come JPEG
Nome #
Nutritional counseling improves quality of life and preserves body weight in systemic immunoglobulin light-chain (AL) amyloidosis 71
A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis 67
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays 67
A patient with AL amyloidosis with negative free light chain results 58
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis 58
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response 54
Urinary albumin to creatinine ratio in diagnosis and risk stratification of renal AL amyloidosis 54
The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis 52
Prognostication of survival and progression to dialysis in AA amyloidosis 50
Patterns of relapse after upfront bortezomib therapy in AL amyloidosis 48
Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome 47
Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcome 46
Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies 46
Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis 45
A practical approach to the diagnosis of systemic amyloidoses 40
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 35
null 30
null 28
Totale 896
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.150
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202050 0 0 0 0 1 0 2 0 1 32 11 3
2020/202134 4 0 0 0 0 1 1 8 16 3 0 1
2021/202268 0 0 0 0 3 0 1 7 4 3 7 43
2022/2023309 33 32 7 18 21 31 0 10 149 1 6 1
2023/2024125 18 23 4 9 10 20 0 6 0 3 16 16
2024/202549 9 18 12 6 4 0 0 0 0 0 0 0
Totale 896